awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53786874-8B2C8E74-C1A1-4A06-9B7E-D1E7E625B1B5
Q53786874-8B2C8E74-C1A1-4A06-9B7E-D1E7E625B1B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53786874-8B2C8E74-C1A1-4A06-9B7E-D1E7E625B1B5
Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer.
P1476
Q53786874-8B2C8E74-C1A1-4A06-9B7E-D1E7E625B1B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53786874-8B2C8E74-C1A1-4A06-9B7E-D1E7E625B1B5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4006e33c123a1e51bc423945fd78baf8d6f6d9c4
P1476
Phase II trial of weekly Docet
......
ion-resistant prostate cancer.
@en